Acting FDA chief seeks pro-life reassurance after Planned Parenthood ties emerge
Acting FDA Commissioner Kyle Diamantas has been telling anti‑abortion leaders he personally opposes abortion while facing questions about past work as outside counsel for a Planned Parenthood Florida clinic (2014–2017) and his later removal from that case for conscience reasons; some filings still list him, prompting skepticism from conservatives. The FDA has pledged a science‑based review of the abortion pill’s REMS and to provide updates, while Diamantas did not respond to questions about the case; the White House defended him amid ongoing debates over mifepristone policy and the agency’s leadership.